Arbutus Biopharma Corp Depreciation
Arbutus Biopharma Corp (ABUS) reported Depreciation of $363.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-23.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-03-23
CAD
| Period end | Depreciation 12 month |
|---|---|
| 2012-12-31 | 865.04K CAD 20-F · filed 2013-03-27 |
| 2011-12-31 | 975.51K CAD 20-F · filed 2013-03-27 |
| 2010-12-31 | 1.04M CAD 20-F · filed 2013-03-27 |
| 2009-12-31 | 988.66K CAD 20-F · filed 2012-03-27 |
USD
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | $363.00K 10-K · filed 2026-03-23 | |||||
| 2024-12-31 | $1.38M 10-K · filed 2026-03-23 | |||||
| 2023-12-31 | $1.40M 10-K · filed 2025-03-27 | |||||
| 2022-12-31 | $1.43M 10-K · filed 2024-03-05 | |||||
| 2021-12-31 | $427.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $874.00K derived: sum of 2 quarters · filed 2023-03-02 | $1.31M derived: sum of 3 quarters · filed 2023-03-02 | $1.75M 10-K · filed 2023-03-02 | ||
| 2021-09-30 | $447.00K 10-Q · filed 2021-11-04 | $883.00K derived: sum of 2 quarters · filed 2021-11-04 | $1.33M 10-Q · filed 2021-11-04 | $1.81M derived: sum of 4 quarters · filed 2022-03-03 | ||
| 2021-06-30 | $436.00K 10-Q · filed 2021-08-05 | $879.00K 10-Q · filed 2021-08-05 | $1.37M derived: sum of 3 quarters · filed 2022-03-03 | $1.86M derived: sum of 4 quarters · filed 2022-03-03 | ||
| 2021-03-31 | $443.00K 10-Q · filed 2021-05-05 | $930.00K derived: sum of 2 quarters · filed 2022-03-03 | $1.42M derived: sum of 3 quarters · filed 2022-03-03 | $1.92M derived: sum of 4 quarters · filed 2022-03-03 | ||
| 2020-12-31 | $487.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $977.00K derived: sum of 2 quarters · filed 2022-03-03 | $1.48M derived: sum of 3 quarters · filed 2022-03-03 | $1.98M 10-K · filed 2022-03-03 | ||
| 2020-09-30 | $490.00K 10-Q · filed 2021-11-04 | $991.00K derived: sum of 2 quarters · filed 2021-11-04 | $1.49M 10-Q · filed 2021-11-04 | $2.00M derived: sum of 4 quarters · filed 2021-11-04 | ||
| 2020-06-30 | $501.00K 10-Q · filed 2021-08-05 | $1.00M 10-Q · filed 2021-08-05 | $1.51M derived: sum of 3 quarters · filed 2021-08-05 | $2.02M derived: sum of 4 quarters · filed 2021-08-05 | ||
| 2020-03-31 | $500.00K 10-Q · filed 2021-05-05 | $1.01M derived: sum of 2 quarters · filed 2021-05-05 | $1.51M derived: sum of 3 quarters · filed 2021-05-05 | $2.02M derived: sum of 4 quarters · filed 2021-05-05 | ||
| 2019-12-31 | $507.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $1.01M derived: sum of 2 quarters · filed 2021-03-04 | $1.52M derived: sum of 3 quarters · filed 2021-03-04 | $2.03M 10-K · filed 2021-03-04 | ||
| 2019-09-30 | $507.00K 10-Q · filed 2020-11-05 | $1.01M derived: sum of 2 quarters · filed 2020-11-05 | $1.52M 10-Q · filed 2020-11-05 | $2.02M derived: sum of 4 quarters · filed 2020-11-05 | ||
| 2019-06-30 | $505.00K 10-Q · filed 2020-08-07 | $1.01M 10-Q · filed 2020-08-07 | $1.52M derived: sum of 3 quarters · filed 2020-08-07 | $2.02M derived: sum of 4 quarters · filed 2020-08-07 | ||
| 2019-03-31 | $509.00K 10-Q · filed 2020-05-11 | $1.01M derived: sum of 2 quarters · filed 2020-05-11 | $1.51M derived: sum of 3 quarters · filed 2020-05-11 | $2.09M derived: sum of 4 quarters · filed 2020-05-11 | ||
| 2018-12-31 | $504.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $1.00M derived: sum of 2 quarters · filed 2020-03-05 | $1.58M derived: sum of 3 quarters · filed 2020-03-05 | $2.18M 10-K · filed 2020-03-05 | ||
| 2018-09-30 | $497.00K 10-Q · filed 2019-11-06 | $1.07M derived: sum of 2 quarters · filed 2019-11-06 | $1.68M 10-Q · filed 2019-11-06 | $2.30M derived: sum of 4 quarters · filed 2019-11-06 | ||
| 2018-06-30 | $578.00K 10-Q · filed 2019-08-05 | $1.18M 10-Q · filed 2019-08-05 | $1.80M derived: sum of 3 quarters · filed 2019-08-05 | $2.39M derived: sum of 4 quarters · filed 2019-08-05 | ||
| 2018-03-31 | $602.00K 10-Q · filed 2019-05-06 | $1.22M derived: sum of 2 quarters · filed 2019-05-06 | $1.81M derived: sum of 3 quarters · filed 2019-05-06 | $2.29M derived: sum of 4 quarters · filed 2019-05-06 | ||
| 2017-12-31 | $620.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $1.21M derived: sum of 2 quarters · filed 2019-03-07 | $1.69M derived: sum of 3 quarters · filed 2019-03-07 | $2.03M 10-K · filed 2019-03-07 | ||
| 2017-09-30 | $593.00K 10-Q · filed 2018-11-07 | $1.07M derived: sum of 2 quarters · filed 2018-11-07 | $1.41M 10-Q · filed 2018-11-07 | $1.74M derived: sum of 4 quarters · filed 2018-11-07 | ||
| 2017-06-30 | $480.00K 10-Q · filed 2018-08-03 | $814.00K 10-Q · filed 2018-08-03 | $1.15M derived: sum of 3 quarters · filed 2018-08-03 | $1.44M derived: sum of 4 quarters · filed 2018-08-03 | ||
| 2017-03-31 | $334.00K 10-Q · filed 2018-05-04 | $666.00K derived: sum of 2 quarters · filed 2018-05-04 | $957.00K derived: sum of 3 quarters · filed 2018-05-04 | $1.21M derived: sum of 4 quarters · filed 2018-05-04 | ||
| 2016-12-31 | $332.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $623.00K derived: sum of 2 quarters · filed 2018-03-16 | $875.00K derived: sum of 3 quarters · filed 2018-03-16 | $1.09M 10-K · filed 2018-03-16 | ||
| 2016-09-30 | $291.00K 10-Q · filed 2017-11-02 | $543.00K derived: sum of 2 quarters · filed 2017-11-02 | $760.00K 10-Q · filed 2017-11-02 | $929.00K derived: sum of 4 quarters · filed 2018-03-16 | ||
| 2016-06-30 | $252.00K 10-Q · filed 2017-08-03 | $469.00K 10-Q · filed 2017-08-03 | $638.00K derived: sum of 3 quarters · filed 2018-03-16 | $791.00K derived: sum of 4 quarters · filed 2018-03-16 | ||
| 2016-03-31 | $217.00K 10-Q · filed 2017-05-04 | $386.00K derived: sum of 2 quarters · filed 2018-03-16 | $539.00K derived: sum of 3 quarters · filed 2018-03-16 | $686.00K derived: sum of 4 quarters · filed 2018-03-16 | ||
| 2015-12-31 | $169.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $322.00K derived: sum of 2 quarters · filed 2018-03-16 | $469.00K derived: sum of 3 quarters · filed 2018-03-16 | $589.00K 10-K · filed 2018-03-16 | ||
| 2015-09-30 | $153.00K 10-Q · filed 2016-11-03 | $300.00K derived: sum of 2 quarters · filed 2016-11-03 | $420.00K 10-Q · filed 2016-11-03 | $533.00K derived: sum of 4 quarters · filed 2017-03-22 | ||
| 2015-06-30 | $147.00K 10-Q · filed 2016-08-04 | $267.00K 10-Q · filed 2016-08-04 | $380.00K derived: sum of 3 quarters · filed 2017-03-22 | $513.00K derived: sum of 4 quarters · filed 2017-03-22 | ||
| 2015-03-31 | $120.00K 10-Q · filed 2016-05-04 | $233.00K derived: sum of 2 quarters · filed 2017-03-22 | $366.00K derived: sum of 3 quarters · filed 2017-03-22 | $515.00K derived: sum of 4 quarters · filed 2017-03-22 | ||
| 2014-12-31 | $113.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22 | $246.00K derived: sum of 2 quarters · filed 2017-03-22 | $395.00K derived: sum of 3 quarters · filed 2017-03-22 | $529.00K 10-K · filed 2017-03-22 | ||
| 2014-09-30 | $133.00K 10-Q · filed 2015-11-05 | $282.00K derived: sum of 2 quarters · filed 2015-11-05 | $416.00K 10-Q · filed 2015-11-05 | $563.00K derived: sum of 4 quarters · filed 2016-03-09 | ||
| 2014-06-30 | $149.00K 10-Q · filed 2015-08-07 | $283.00K 10-Q · filed 2015-08-07 | $430.00K derived: sum of 3 quarters · filed 2016-03-09 | $578.00K derived: sum of 4 quarters · filed 2016-03-09 | ||
| 2014-03-31 | $134.00K 10-Q · filed 2015-05-06 | $281.00K derived: sum of 2 quarters · filed 2016-03-09 | $429.00K derived: sum of 3 quarters · filed 2016-03-09 | $577.00K derived: sum of 4 quarters · filed 2016-03-09 | ||
| 2013-12-31 | $147.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | $295.00K derived: sum of 2 quarters · filed 2016-03-09 | $443.00K derived: sum of 3 quarters · filed 2016-03-09 | $613.00K 10-K · filed 2016-03-09 | $612.84K 6-K · filed 2014-03-06 | |
| 2013-09-30 | $148.00K 10-Q · filed 2014-11-07 | $296.00K derived: sum of 2 quarters · filed 2014-11-07 | $466.00K 10-Q · filed 2014-11-07 | |||
| 2013-06-30 | $148.00K 10-Q · filed 2014-11-07 | $152.00K 10-Q · filed 2014-08-14 | $318.00K 10-Q · filed 2014-08-14 | |||
| 2013-03-31 | $166.00K 10-Q · filed 2014-05-14 | |||||
| 2012-12-31 | $866.00K 10-K · filed 2015-03-13 | $865.60K 6-K · filed 2014-03-06 | ||||
| 2011-12-31 | $986.93K 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |